Trials that use: Fisher exact test
New to this method? Read the tutorial →
5,849 results
- Sugammadex and Quantitative Monitoring in “Fast-Track Anesthesia” During Liver Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Sugammadex and Quantitative Monitoring in "Fast-Track Anesthesia" During Liver Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05216991).
- Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular: Complete Statistical AnalysisIndependent statistical analysis of Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03322657).
- SUHRIIndependent statistical analysis of The Substance Use and Health Risk Intervention (SUHRI) for Justice-involved Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SUMMITIndependent statistical analysis of A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SUMMIT-LTSIndependent statistical analysis of Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sunitinib Malate in Refractory Germ Cell Tumors: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate in Refractory Germ Cell Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00912912).
- Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux: Complete Statistical AnalysisIndependent statistical analysis of Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01499953).
- Supported Employment in Patient Aligned Care Teams: Complete Statistical AnalysisIndependent statistical analysis of Supported Employment in Patient Aligned Care Teams: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02400736).
- Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01352416).
- Suppression of HIV 1 RNA in People Living With HIV: Complete Statistical AnalysisIndependent statistical analysis of Suppression of HIV 1 RNA in People Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02363387).
- Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm: Complete Statistical AnalysisIndependent statistical analysis of Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00739401).
- SUPREMEIndependent statistical analysis of Sonendo GentleWave™ System for Treatment in Molar Teeth Requiring Root Canal Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.: Complete Statistical AnalysisIndependent statistical analysis of SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Surgeon Infiltration QL Block Comparison: Complete Statistical AnalysisIndependent statistical analysis of Surgeon Infiltration QL Block Comparison: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03496610).
- Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix: Complete Statistical AnalysisIndependent statistical analysis of Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation: Complete Statistical AnalysisIndependent statistical analysis of Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen: Complete Statistical AnalysisIndependent statistical analysis of Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SURPASSIndependent statistical analysis of Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SURV1VEIndependent statistical analysis of SI + CC Versus 3:1 C:V Ratio During Neonatal CPR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02858583).
- SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine: Complete Statistical AnalysisIndependent statistical analysis of Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SWAP-ACIndependent statistical analysis of Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease: primary endpoint results, effect estimate with confidence interval,…
- SWARM-PaIndependent statistical analysis of Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis: primary endpoint results, effect estimate with confidence…
- SWEDESIndependent statistical analysis of Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SWIFTIndependent statistical analysis of Safety and Efficacy Study of Switching From Epzicom to Truvada: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00724711).
- SWIFTIndependent statistical analysis of SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01054560).
- SWIPEIndependent statistical analysis of Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SWITCHIndependent statistical analysis of Sleep Without Insomnia or The Use of Chronic Hypnotics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03687086).
- SWITCH 2Independent statistical analysis of A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes: primary endpoint results, effect estimate…
- Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years: Complete Statistical AnalysisIndependent statistical analysis of Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years: primary endpoint…
- Sym004 in Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Sym004 in Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01117428).
- SYMPATICOIndependent statistical analysis of Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SYMPHONYextIndependent statistical analysis of Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Symplicity AFIndependent statistical analysis of Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Symptoms-StepsIndependent statistical analysis of In Person and mHealth Coping Skills Training for Symptom Management and Steps in Stem Cell Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Synagis RussiaIndependent statistical analysis of A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and…
- T-cell Depleted Alternative Donor Transplantation: Complete Statistical AnalysisIndependent statistical analysis of T-cell Depleted Alternative Donor Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00968864).
- T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery: Complete Statistical AnalysisIndependent statistical analysis of T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00939653).
- TACACIndependent statistical analysis of Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00206518).
- Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer: primary endpoint results,…
- TACTIC AFIndependent statistical analysis of Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…